Search

Your search keyword '"Usmani, Saad Z"' showing total 36 results
Start Over Author "Usmani, Saad Z" Publisher american association for cancer research (aacr)
36 results on '"Usmani, Saad Z"'

3. Data from Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Author

Davies, Faith E., primary, Pawlyn, Charlotte, primary, Usmani, Saad Z., primary, San-Miguel, Jesus F., primary, Einsele, Hermann, primary, Boyle, Eileen M., primary, Corre, Jill, primary, Auclair, Daniel, primary, Cho, Hearn Jay, primary, Lonial, Sagar, primary, Sonneveld, Pieter, primary, Stewart, A. Keith, primary, Bergsagel, P. Leif, primary, Kaiser, Martin F., primary, Weisel, Katja, primary, Keats, Jonathan J., primary, Mikhael, Joseph R., primary, Morgan, Kathryn E., primary, Ghobrial, Irene M., primary, Orlowski, Robert Z., primary, Landgren, C. Ola, primary, Gay, Francesca, primary, Caers, Joseph, primary, Chng, Wee Joo, primary, Chari, Ajai, primary, Walker, Brian A., primary, Kumar, Shaji K., primary, Costa, Luciano J., primary, Anderson, Kenneth C., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table from Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Author

Davies, Faith E., primary, Pawlyn, Charlotte, primary, Usmani, Saad Z., primary, San-Miguel, Jesus F., primary, Einsele, Hermann, primary, Boyle, Eileen M., primary, Corre, Jill, primary, Auclair, Daniel, primary, Cho, Hearn Jay, primary, Lonial, Sagar, primary, Sonneveld, Pieter, primary, Stewart, A. Keith, primary, Bergsagel, P. Leif, primary, Kaiser, Martin F., primary, Weisel, Katja, primary, Keats, Jonathan J., primary, Mikhael, Joseph R., primary, Morgan, Kathryn E., primary, Ghobrial, Irene M., primary, Orlowski, Robert Z., primary, Landgren, C. Ola, primary, Gay, Francesca, primary, Caers, Joseph, primary, Chng, Wee Joo, primary, Chari, Ajai, primary, Walker, Brian A., primary, Kumar, Shaji K., primary, Costa, Luciano J., primary, Anderson, Kenneth C., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

5. Supplementary Table from Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Author

Davies, Faith E., primary, Pawlyn, Charlotte, primary, Usmani, Saad Z., primary, San-Miguel, Jesus F., primary, Einsele, Hermann, primary, Boyle, Eileen M., primary, Corre, Jill, primary, Auclair, Daniel, primary, Cho, Hearn Jay, primary, Lonial, Sagar, primary, Sonneveld, Pieter, primary, Stewart, A. Keith, primary, Bergsagel, P. Leif, primary, Kaiser, Martin F., primary, Weisel, Katja, primary, Keats, Jonathan J., primary, Mikhael, Joseph R., primary, Morgan, Kathryn E., primary, Ghobrial, Irene M., primary, Orlowski, Robert Z., primary, Landgren, C. Ola, primary, Gay, Francesca, primary, Caers, Joseph, primary, Chng, Wee Joo, primary, Chari, Ajai, primary, Walker, Brian A., primary, Kumar, Shaji K., primary, Costa, Luciano J., primary, Anderson, Kenneth C., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

6. Data from Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Author

Davies, Faith E., primary, Pawlyn, Charlotte, primary, Usmani, Saad Z., primary, San-Miguel, Jesus F., primary, Einsele, Hermann, primary, Boyle, Eileen M., primary, Corre, Jill, primary, Auclair, Daniel, primary, Cho, Hearn Jay, primary, Lonial, Sagar, primary, Sonneveld, Pieter, primary, Stewart, A. Keith, primary, Bergsagel, P. Leif, primary, Kaiser, Martin F., primary, Weisel, Katja, primary, Keats, Jonathan J., primary, Mikhael, Joseph R., primary, Morgan, Kathryn E., primary, Ghobrial, Irene M., primary, Orlowski, Robert Z., primary, Landgren, C. Ola, primary, Gay, Francesca, primary, Caers, Joseph, primary, Chng, Wee Joo, primary, Chari, Ajai, primary, Walker, Brian A., primary, Kumar, Shaji K., primary, Costa, Luciano J., primary, Anderson, Kenneth C., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table from Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Author

Davies, Faith E., primary, Pawlyn, Charlotte, primary, Usmani, Saad Z., primary, San-Miguel, Jesus F., primary, Einsele, Hermann, primary, Boyle, Eileen M., primary, Corre, Jill, primary, Auclair, Daniel, primary, Cho, Hearn Jay, primary, Lonial, Sagar, primary, Sonneveld, Pieter, primary, Stewart, A. Keith, primary, Bergsagel, P. Leif, primary, Kaiser, Martin F., primary, Weisel, Katja, primary, Keats, Jonathan J., primary, Mikhael, Joseph R., primary, Morgan, Kathryn E., primary, Ghobrial, Irene M., primary, Orlowski, Robert Z., primary, Landgren, C. Ola, primary, Gay, Francesca, primary, Caers, Joseph, primary, Chng, Wee Joo, primary, Chari, Ajai, primary, Walker, Brian A., primary, Kumar, Shaji K., primary, Costa, Luciano J., primary, Anderson, Kenneth C., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table from Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Author

Davies, Faith E., primary, Pawlyn, Charlotte, primary, Usmani, Saad Z., primary, San-Miguel, Jesus F., primary, Einsele, Hermann, primary, Boyle, Eileen M., primary, Corre, Jill, primary, Auclair, Daniel, primary, Cho, Hearn Jay, primary, Lonial, Sagar, primary, Sonneveld, Pieter, primary, Stewart, A. Keith, primary, Bergsagel, P. Leif, primary, Kaiser, Martin F., primary, Weisel, Katja, primary, Keats, Jonathan J., primary, Mikhael, Joseph R., primary, Morgan, Kathryn E., primary, Ghobrial, Irene M., primary, Orlowski, Robert Z., primary, Landgren, C. Ola, primary, Gay, Francesca, primary, Caers, Joseph, primary, Chng, Wee Joo, primary, Chari, Ajai, primary, Walker, Brian A., primary, Kumar, Shaji K., primary, Costa, Luciano J., primary, Anderson, Kenneth C., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

9. Supplementary fig 1 from Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets

Author

Shah, Urvi A., primary, Maclachlan, Kylee H., primary, Derkach, Andriy, primary, Salcedo, Meghan, primary, Barnett, Kelly, primary, Caple, Julia, primary, Blaslov, Jenna, primary, Tran, Linh, primary, Ciardiello, Amanda, primary, Burge, Miranda, primary, Shekarkhand, Tala, primary, Adintori, Peter, primary, Cross, Justin, primary, Pianko, Matthew J., primary, Hosszu, Kinga, primary, McAvoy, Devin, primary, Mailankody, Sham, primary, Korde, Neha, primary, Hultcrantz, Malin, primary, Hassoun, Hani, primary, Tan, Carlyn R., primary, Lu, Sydney X., primary, Patel, Dhwani, primary, Diamond, Benjamin, primary, Shah, Gunjan, primary, Scordo, Michael, primary, Lahoud, Oscar, primary, Chung, David J., primary, Landau, Heather, primary, Usmani, Saad Z., primary, Giralt, Sergio, primary, Taur, Ying, primary, Landgren, C. Ola, primary, Block, Gladys, primary, Block, Torin, primary, Peled, Jonathan U., primary, van den Brink, Marcel R.M., primary, and Lesokhin, Alexander M., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 1 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 1 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

12. Figure S1 from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., primary, Casper, Corey, primary, Furman, Richard R., primary, Fayad, Luis, primary, Lonial, Sagar, primary, Borghaei, Hossein, primary, Jagannath, Sundar, primary, Sokol, Lubomir, primary, Usmani, Saad Z., primary, van de Velde, Helgi, primary, Qin, Xiang, primary, Puchalski, Thomas A., primary, Hall, Brett, primary, Reddy, Manjula, primary, Qi, Ming, primary, and van Rhee, Frits, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 1 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 2 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure 3 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure Legend from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 1 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Methods from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., primary, Casper, Corey, primary, Furman, Richard R., primary, Fayad, Luis, primary, Lonial, Sagar, primary, Borghaei, Hossein, primary, Jagannath, Sundar, primary, Sokol, Lubomir, primary, Usmani, Saad Z., primary, van de Velde, Helgi, primary, Qin, Xiang, primary, Puchalski, Thomas A., primary, Hall, Brett, primary, Reddy, Manjula, primary, Qi, Ming, primary, and van Rhee, Frits, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure 4 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Methods from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., primary, Casper, Corey, primary, Furman, Richard R., primary, Fayad, Luis, primary, Lonial, Sagar, primary, Borghaei, Hossein, primary, Jagannath, Sundar, primary, Sokol, Lubomir, primary, Usmani, Saad Z., primary, van de Velde, Helgi, primary, Qin, Xiang, primary, Puchalski, Thomas A., primary, Hall, Brett, primary, Reddy, Manjula, primary, Qi, Ming, primary, and van Rhee, Frits, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 4 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

22. Figure S1 from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., primary, Casper, Corey, primary, Furman, Richard R., primary, Fayad, Luis, primary, Lonial, Sagar, primary, Borghaei, Hossein, primary, Jagannath, Sundar, primary, Sokol, Lubomir, primary, Usmani, Saad Z., primary, van de Velde, Helgi, primary, Qin, Xiang, primary, Puchalski, Thomas A., primary, Hall, Brett, primary, Reddy, Manjula, primary, Qi, Ming, primary, and van Rhee, Frits, primary

Published
2023
Full Text
View/download PDF

23. Figure S2 from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., primary, Casper, Corey, primary, Furman, Richard R., primary, Fayad, Luis, primary, Lonial, Sagar, primary, Borghaei, Hossein, primary, Jagannath, Sundar, primary, Sokol, Lubomir, primary, Usmani, Saad Z., primary, van de Velde, Helgi, primary, Qin, Xiang, primary, Puchalski, Thomas A., primary, Hall, Brett, primary, Reddy, Manjula, primary, Qi, Ming, primary, and van Rhee, Frits, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure Legend from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table S1 from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., primary, Casper, Corey, primary, Furman, Richard R., primary, Fayad, Luis, primary, Lonial, Sagar, primary, Borghaei, Hossein, primary, Jagannath, Sundar, primary, Sokol, Lubomir, primary, Usmani, Saad Z., primary, van de Velde, Helgi, primary, Qin, Xiang, primary, Puchalski, Thomas A., primary, Hall, Brett, primary, Reddy, Manjula, primary, Qi, Ming, primary, and van Rhee, Frits, primary

Published
2023
Full Text
View/download PDF

26. Figure S2 from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., primary, Casper, Corey, primary, Furman, Richard R., primary, Fayad, Luis, primary, Lonial, Sagar, primary, Borghaei, Hossein, primary, Jagannath, Sundar, primary, Sokol, Lubomir, primary, Usmani, Saad Z., primary, van de Velde, Helgi, primary, Qin, Xiang, primary, Puchalski, Thomas A., primary, Hall, Brett, primary, Reddy, Manjula, primary, Qi, Ming, primary, and van Rhee, Frits, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure 2 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table S1 from A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., primary, Casper, Corey, primary, Furman, Richard R., primary, Fayad, Luis, primary, Lonial, Sagar, primary, Borghaei, Hossein, primary, Jagannath, Sundar, primary, Sokol, Lubomir, primary, Usmani, Saad Z., primary, van de Velde, Helgi, primary, Qin, Xiang, primary, Puchalski, Thomas A., primary, Hall, Brett, primary, Reddy, Manjula, primary, Qi, Ming, primary, and van Rhee, Frits, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 5 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, primary, Hansen, Emily, primary, Shaughnessy, John D., primary, Usmani, Saad Z., primary, van Rhee, Frits, primary, Anaissie, Elias, primary, Nair, Bijay, primary, Waheed, Sarah, primary, Alsayed, Yazan, primary, Petty, Nathan, primary, Bailey, Clyde, primary, Epstein, Joshua, primary, Hoering, Antje, primary, Crowley, John, primary, and Barlogie, Bart, primary

Published
2023
Full Text
View/download PDF

30. Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets

Author

Shah, Urvi A., primary, Maclachlan, Kylee H., additional, Derkach, Andriy, additional, Salcedo, Meghan, additional, Barnett, Kelly, additional, Caple, Julia, additional, Blaslov, Jenna, additional, Tran, Linh, additional, Ciardiello, Amanda, additional, Burge, Miranda, additional, Shekarkhand, Tala, additional, Adintori, Peter, additional, Cross, Justin, additional, Pianko, Matthew J., additional, Hosszu, Kinga, additional, McAvoy, Devin, additional, Mailankody, Sham, additional, Korde, Neha, additional, Hultcrantz, Malin, additional, Hassoun, Hani, additional, Tan, Carlyn R., additional, Lu, Sydney X., additional, Patel, Dhwani, additional, Diamond, Benjamin, additional, Shah, Gunjan, additional, Scordo, Michael, additional, Lahoud, Oscar, additional, Chung, David J., additional, Landau, Heather, additional, Usmani, Saad Z., additional, Giralt, Sergio, additional, Taur, Ying, additional, Landgren, C. Ola, additional, Block, Gladys, additional, Block, Torin, additional, Peled, Jonathan U., additional, van den Brink, Marcel R.M., additional, and Lesokhin, Alexander M., additional

Published
2022
Full Text
View/download PDF

31. Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Author

Davies, Faith E., primary, Pawlyn, Charlotte, additional, Usmani, Saad Z., additional, San-Miguel, Jesus F., additional, Einsele, Hermann, additional, Boyle, Eileen M., additional, Corre, Jill, additional, Auclair, Daniel, additional, Cho, Hearn Jay, additional, Lonial, Sagar, additional, Sonneveld, Pieter, additional, Stewart, A. Keith, additional, Bergsagel, P. Leif, additional, Kaiser, Martin F., additional, Weisel, Katja, additional, Keats, Jonathan J., additional, Mikhael, Joseph R., additional, Morgan, Kathryn E., additional, Ghobrial, Irene M., additional, Orlowski, Robert Z., additional, Landgren, C. Ola, additional, Gay, Francesca, additional, Caers, Joseph, additional, Chng, Wee Joo, additional, Chari, Ajai, additional, Walker, Brian A., additional, Kumar, Shaji K., additional, Costa, Luciano J., additional, Anderson, Kenneth C., additional, and Morgan, Gareth J., additional

Published
2022
Full Text
View/download PDF

35. A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Author

Kurzrock, Razelle, primary, Voorhees, Peter M., additional, Casper, Corey, additional, Furman, Richard R., additional, Fayad, Luis, additional, Lonial, Sagar, additional, Borghaei, Hossein, additional, Jagannath, Sundar, additional, Sokol, Lubomir, additional, Usmani, Saad Z., additional, van de Velde, Helgi, additional, Qin, Xiang, additional, Puchalski, Thomas A., additional, Hall, Brett, additional, Reddy, Manjula, additional, Qi, Ming, additional, and van Rhee, Frits, additional

Published
2013
Full Text
View/download PDF

36. Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1

Author

Heuck, Christoph J., primary, Szymonifka, Jackie, additional, Hansen, Emily, additional, Shaughnessy, John D., additional, Usmani, Saad Z., additional, van Rhee, Frits, additional, Anaissie, Elias, additional, Nair, Bijay, additional, Waheed, Sarah, additional, Alsayed, Yazan, additional, Petty, Nathan, additional, Bailey, Clyde, additional, Epstein, Joshua, additional, Hoering, Antje, additional, Crowley, John, additional, and Barlogie, Bart, additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results